|
|
Schaefer, N. G., Huang, P., Buchanan, J. W., & Wahl, R. L. (2011). Radioimmunotherapy in non-Hodgkin lymphoma: opinions of nuclear medicine physicians and radiation oncologists. Journal of Nuclear Medicine, 52(5), 830–838.
|
|
|
|
Vermeulen, K., Vandamme, M., Bormans, G., & Cleeren, F. (2019). Design and challenges of radiopharmaceuticals. In Seminars in nuclear medicine (Vol. 49, pp. 339–356). Elsevier.
|
|
|
|
Notni, J., & Wester, H. - J. (2018). Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals. Journal of Labelled Compounds and Radiopharmaceuticals, 61(3), 141–153.
|
|
|
|
Brugarolas, P., Comstock, J., Dick, D. W., Ellmer, T., Engle, J. W., Lapi, S. E., et al. (2020). Fifty Years of Radiopharmaceuticals. Journal of Nuclear Medicine Technology, 48(Supplement 1), 34s–39s.
|
|
|
|
Canton, L., & Fontana, A. (2020). Nuclear physics applied to the production of innovative radiopharmaceuticals. The European Physical Journal Plus, 135(9), 1–21.
|
|
